0,05MG/ML+5MG/ML OPH GTT SOL 1X2,5ML
Announcement of launch, break or close-out of marketing of a medicinal product
|Type of announcement||Effective date||Alternate medicines ?||Reason for interruption/cessation of marketing||Estimated renewal date|
|Resumption of marketing||14.02.2022|
|Interruption of marketing||01.12.2021||
|Placing on the market||07.07.2020|
All reports are available in the Overview.